Zoology Department, College of Sciences, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia.
Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
Molecules. 2024 Feb 25;29(5):998. doi: 10.3390/molecules29050998.
We provide promising computational (in silico) data on phytochemicals (compounds -) from Arabian Peninsula medicinal plants as strong binders, targeting 3-chymotrypsin-like protease (3CL) and papain-like proteases (PL) of SARS-CoV-2. Compounds - followed the Lipinski rules of five (RO5) and ADMET analysis, exhibiting drug-like characters. Non-covalent (reversible) docking of compounds - demonstrated their binding with the catalytic dyad (CYS145 and HIS41) of 3CL and catalytic triad (CYS111, HIS272, and ASP286) of PL. Moreover, the implementation of the covalent (irreversible) docking protocol revealed that only compounds , , and possess covalent warheads, which allowed the formation of the covalent bond with the catalytic dyad (CYS145) in 3CL and the catalytic triad (CYS111) in PL. Root-mean-square deviation (RMSD), root-mean-square fluctuation (RMSF), and radius of gyration (Rg) analysis from molecular dynamic (MD) simulations revealed that complexation between ligands (compounds , , and ) and 3CL and PL was stable, and there was less deviation of ligands. Overall, the in silico data on the inherent properties of the above phytochemicals unravel the fact that they can act as reversible inhibitors for 3CL and PL. Moreover, compounds , , and also showed their novel properties to inhibit dual targets by irreversible inhibition, indicating their effectiveness for possibly developing future drugs against SARS-CoV-2. Nonetheless, to confirm the theoretical findings here, the effectiveness of the above compounds as inhibitors of 3CL and PL warrants future investigations using suitable in vitro and in vivo tests.
我们提供了来自阿拉伯半岛药用植物的植物化学物质(化合物-)作为强力结合物针对 SARS-CoV-2 的 3-胰凝乳蛋白酶样蛋白酶(3CL)和木瓜蛋白酶样蛋白酶(PL)的有前景的计算(计算机模拟)数据。化合物-符合 Lipinski 五规则(RO5)和 ADMET 分析,表现出类药性特征。化合物-的非共价(可逆)对接表明它们与 3CL 的催化二联体(CYS145 和 HIS41)和 PL 的催化三联体(CYS111、HIS272 和 ASP286)结合。此外,共价(不可逆)对接方案的实施表明,只有化合物-、-和-具有共价弹头,这允许与 3CL 中的催化二联体(CYS145)和 PL 中的催化三联体(CYS111)形成共价键。来自分子动力学(MD)模拟的均方根偏差(RMSD)、均方根波动(RMSF)和旋转半径(Rg)分析表明,配体(化合物-、-和-)与 3CL 和 PL 之间的络合是稳定的,配体的偏差较小。总体而言,上述植物化学物质固有特性的计算机数据表明,它们可以作为 3CL 和 PL 的可逆抑制剂。此外,化合物-、-和-还显示出通过不可逆抑制抑制双重靶标的新特性,表明它们在开发针对 SARS-CoV-2 的未来药物方面具有有效性。尽管如此,为了证实这里的理论发现,需要使用合适的体外和体内试验来进一步研究上述化合物作为 3CL 和 PL 抑制剂的有效性。